- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
OCLN antibody recognizes Occludin, a four-pass transmembrane tight junction protein encoded by the OCLN gene that is essential for epithelial and endothelial barrier integrity. OCLN Antibody Recombinant Monoclonal is designed to detect this junctional protein that regulates paracellular permeability and maintains apical-basal polarity in organized tissues. Occludin localizes primarily to the plasma membrane at tight junction complexes, forming continuous belt-like structures at cell-cell borders where it interacts with claudins, TJP1, and the actin cytoskeleton.
Occludin antibody, also referred to as OCLN antibody and tight junction Occludin antibody in the literature, targets a structural component widely expressed in epithelial tissues including intestine, kidney, lung, and liver, as well as in endothelial barriers such as the blood-brain barrier. Within cells, Occludin is concentrated at apical junctional complexes and plays a central role in controlling selective permeability between adjacent cells. Loss of membrane localization or reduced expression of Occludin is frequently associated with increased barrier permeability and tissue injury.
Structurally, Occludin contains four transmembrane domains, two extracellular loops, and cytoplasmic N-terminal and C-terminal domains. The C-terminal cytoplasmic region is critical for tight junction assembly and interaction with scaffolding proteins such as TJP1. Post-translational modifications including phosphorylation regulate Occludin trafficking, tight junction stability, and barrier function. Altered phosphorylation can lead to redistribution away from junctional membranes and contribute to inflammatory and ischemic barrier dysfunction.
Changes in OCLN expression have been implicated in inflammatory bowel disease, acute lung injury, renal ischemia-reperfusion injury, and blood-brain barrier disruption. In cancer biology, tight junction remodeling and altered Occludin expression can influence tumor cell polarity and invasion by modifying intercellular adhesion. Because barrier breakdown is a hallmark of numerous pathological processes, OCLN antibody remains an important tool for studying epithelial integrity and junctional organization.
This recombinant mouse monoclonal antibody clone rOCLN/8525 targets Occludin for research applications involving tight junction biology, epithelial barrier regulation, and tissue injury models. By enabling detection of OCLN expression and localization, this Occludin antibody supports investigations into barrier function and junctional protein dynamics at NSJ Bioreagents.
Optimal dilution of the OCLN antibody should be determined by the researcher.
A recombinant human protein fragment (within amino acids 282-415) was used as the immunogen for the OCLN antibody.
Aliquot the OCLN antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.